Equivalent Transdermal Testosterone Dosing for Menopausal Women
For a menopausal woman receiving 20 mg weekly intramuscular testosterone, the equivalent daily transdermal testosterone cream dose would be approximately 2.9 mg/day (calculated as 20 mg ÷ 7 days), though in clinical practice, starting with 5 mg daily transdermal testosterone cream is recommended with subsequent dose titration based on serum testosterone levels and symptom response.
Dosing Conversion Rationale
The conversion from intramuscular to transdermal testosterone is not straightforward due to differences in bioavailability and pharmacokinetics between routes:
Mathematical Conversion
- Weekly IM dose: 20 mg/week
- Daily equivalent: 20 mg ÷ 7 = approximately 2.9 mg/day
- However, this simple calculation doesn't account for bioavailability differences
Evidence-Based Transdermal Dosing in Women
Transdermal testosterone cream/gel dosing for postmenopausal women typically ranges from 5-10 mg daily based on clinical research 1, 2, 3:
- 5 mg daily transdermal testosterone cream restores total and free testosterone to levels within or above the premenopausal reference range 3
- Studies demonstrate that 4.4 mg daily testosterone gel raises testosterone levels into the mid- to high-normal range for women 2
- 10 mg daily testosterone cream has been shown effective and safe in clinical trials for menopausal women 1, 4
Practical Clinical Approach
Start with 5 mg daily transdermal testosterone cream applied to the upper arm or thigh 1, 3, 4. This dose is supported by pharmacokinetic studies showing:
- 5 mg transdermal cream produces average steady-state total testosterone of 0.54 ng/mL (uncorrected) and free testosterone of 4.14 pg/mL 3
- This achieves physiologic replacement without supraphysiologic levels
- The 5 mg dose is well-tolerated with minimal side effects 4, 5
Monitoring and Titration
Measure serum testosterone levels 2-4 weeks after initiating therapy 6:
- Target mid-normal range for premenopausal women
- If levels are subtherapeutic or symptoms persist, increase to 10 mg daily
- Doubling the dose from 5 to 10 mg increases testosterone levels by approximately 30% 3
- Monitor for side effects (acne, hirsutism) which are typically mild and reversible 4, 7, 8
Important Caveats
Bioavailability Differences
Intramuscular testosterone produces fluctuating levels with peaks and valleys 9, while transdermal preparations provide more stable serum concentrations 9. This means direct mg-to-mg conversion is imprecise.
No FDA-Approved Formulation for Women
There is currently no FDA-approved testosterone formulation specifically designed for women in the United States 10, 8, 11. Women must use:
- Compounded preparations (variable quality)
- Male formulations at reduced doses (challenging to dose accurately) 5
- Off-label use requires informed consent and careful monitoring
Application Technique Matters
- Apply to clean, dry skin of upper arms, shoulders, or thighs 12, 1
- Cover application site with clothing after drying to prevent transfer 12
- Avoid washing application site for minimum 2 hours 12
Safety Monitoring
Monitor at 3-6 months initially, then every 6-12 months 6:
- Serum testosterone levels
- Lipid profile
- Hematocrit (though less concern in women than men)
- Clinical assessment of symptoms and side effects
- Breast and cardiovascular health per standard guidelines 10, 13
Clinical Bottom Line
Begin with 5 mg daily transdermal testosterone cream rather than attempting a direct mathematical conversion from the 20 mg weekly IM dose. This evidence-based starting dose provides physiologic testosterone replacement in most postmenopausal women 1, 2, 3, 4. Titrate based on serum levels and symptom response, with 10 mg daily as the typical maximum dose 1, 5. The transdermal route offers more stable hormone levels and potentially better safety profile compared to injections 9.